Candel Therapeutics Inc. (NASDAQ: CADL)
$8.9200
-1.0400 ( -2.41% ) 3.2M
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.
Market Data
Open
$8.9200
Previous close
$9.9600
Volume
3.2M
Market cap
$418.96M
Day range
$8.6830 - $9.9800
52 week range
$1.0600 - $14.6000
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Dec 18, 2024 |
4 | Insider transactions | 1 | Dec 13, 2024 |
8-k | 8K-related | 21 | Dec 13, 2024 |
8-k | 8K-related | 57 | Dec 11, 2024 |
4 | Insider transactions | 1 | Dec 06, 2024 |
4 | Insider transactions | 1 | Dec 03, 2024 |
4 | Insider transactions | 1 | Dec 03, 2024 |
4 | Insider transactions | 1 | Dec 03, 2024 |
4 | Insider transactions | 1 | Dec 03, 2024 |
4 | Insider transactions | 1 | Nov 27, 2024 |